Combining proprietary medications and a targeted micro-dosing implantable delivery method will address the well-recognized limitations of oral medications including poor effectiveness, side effects, dosing limitations, variation in drug levels, limitations of the blood brain barrier and patient compliance. 

Cerebral Therapeutics approach takes advantage of targeted drug delivery including identifying specific targeted brain drug levels, lowering systemic exposure of medication agents and improving patient adherence.